Axiom Catalyst

Asia’s oncology landscape is changing fast. In this latest Axiom Catalyst episode, the #AxiomThinkTank India team and top regional experts, including 𝗗𝗿. 𝗞𝗼𝗵𝗲𝗶 𝗦𝗵𝗶𝘁𝗮𝗿𝗮, who focuses on innovative therapies for gastrointestinal cancers, and Dr. Vanita Noronha , who specializes in enhancing treatment options for geriatric oncology patients, dig into the most exciting #ESMO2025 breakthroughs - from no...

In this episode of the Axiom Catalyst Life Sciences Podcast , Jai Bains speaks with Dr. Gayathri Swaminath , VP of Cardiovascular at Pioneering Medicines, about the evolving role of pre-emptive medicine in cardiometabolic renal disease, with a focus on chronic kidney disease. From redefining early intervention to exploring the role of biomarkers, and multi-omics, this conversation dives into the s...

Chiranth Achar discussed the rare disease landscape in India with Prasanna Shirol, Co-founder & Director of the  Organization for Rare Diseases India . The ORDI would like to make listeners aware of the significant work done by them in aid of rare disease patient in India. This includes India’s First Rare Disease Helpline: (+91) 8892 555 000, the  Savemylife  patient support program,  Racefor7...

Dan Simpson connected with  Prof. Dave Pearce , Chair of the  International Rare Diseases Research Consortium ( IRDiRC )  and professor of pediatric rare diseases. Prof. Pearce speaks passionately about the needs of rare disease patients around the world, and how the IRDiRC brings together funding agencies, companies, patient advocate groups, and other organization from approximately 80 countries...

Marissa McPhillips met Michelle, in her capacity as CEO of  Alltrna , for a constructive conversation around the critical role industry plays in developing innovative treatments for rare disease. We heard how it takes an environment that supports innovation, with incentives, novel clinical trial designs, and other enabling regulations – with Michelle urging the rare disease community to continue t...

Seona Lee and  Dr Brandsema , pediatric neurologist at  CHOP , discuss his firsthand specialist physician’s experience in treating rare disease patients – including the challenges, progress and hope for 2025. Listen in for some inspiring patient stories. Check out the work CHOP is doing to improve the lives of patients with Duchenne’s (DMD)  here .

What does it take to navigate through the complex question of when and with whom to partner for a companion diagnostic? Join us in yet another invigorating episode at #AxiomCatalystPodcast where Anne Cherry hosts top industry experts, Kara O'Brien and Tricia Carrigan to share invaluable insights on: ✅ Choosing the right technology ✅ Deciding between in-house development and partnerships ✅ Timin...

Go-to-Market Strategies: In this dynamic panel discussion moderated by the Managing Principal of Axiom Healthcare Strategies, experts dive into innovative strategies that are reshaping how pharma companies bring new therapies to market. From leveraging advanced data analytics to navigating regulatory pathways, the conversation covers key approaches to speed up launches and maximize impact for pati...

Industry at a Crossroads – Presented by Jon Yoder, Managing Director of Axiom Healthcare Strategies, this insightful session explores the pivotal challenges and opportunities shaping the future of the healthcare industry. Don’t miss these strategic perspectives on where the industry is headed. To learn more about the future of the biotech industry and its investor ecosystem, reach out to Jon at jy...

Best Foot Forward: Optimizing Clinical Trials during Today's Crossroads – Moderated by Giovanni Abbadessa of ModeX, this insightful panel features Lisa Mahnke of Nerviano Medical Sciences and Christiana Bardon of MPM. Discover how these leaders are optimizing clinical trials and evaluating asset strength in today's rapidly evolving healthcare landscape. To learn more about how we can help you deve...

Crossroads Between Oncology & Rare Diseases – Moderated by Anne Cherry, this panel features Michelle Werner from Alltrna. Explore the critical intersections of oncology and rare diseases, and how insights from one world can provide insight to the other. Watch the full panel here: https://www.youtube.com/watch?v=1e6Ozg2_YL0 To learn more about our work supporting companies driving innovation ac...

Reimagining Clinical Trials – A thought-provoking panel moderated by the Managing Principal of Axiom Healthcare Strategies, featuring exertise among physicians and industry leaders: Hossein Borghaei, Corey Langer, Shruti Agrawal, Robert LaCaze, Alan Bash, and Nicholas Davies. Explore innovative approaches transforming traditional trial models. To learn more about our work supporting innovation in...

CEO and Founder Spotlight – A dynamic panel moderated by the Managing Principal of Axiom Healthcare Strategies, featuring industry leaders, Alan Bash, Lea Hachigian, Robert LaCaze, and Michelle Werner. Dive into their journeys, insights, and visions for the future of healthcare. To learn more about how Axiom supports biotech leaders and their organizations to excel, reach out to our Chief of Strat...

Anne Cherry, Chief of Strategy at Axiom Healthcare Strategies, dives deep into identifying gaps and opportunities across the product development lifecycle. Learn how strategic insights are transforming patient outcomes and driving innovation. #AxiomCrossroads #BeBio #AxiomThinkTank

Partnering for Innovation – A powerful discussion led by Paul Biondi of Flagship Pioneering at the Axiom Crossroads Summit! Explore insights on how groundbreaking collaborations are shaping the future of healthcare and driving innovation. #AxiomCrossroads #BeBio #AxiomThinkTank

From the first new treatment in locally advanced cervical cancer in over a decade to buzz around exciting new drugs in development for ovarian and endometrial cancer, there have been many advances made in gynecologic cancer treatment in the past 12 months.  In this Gynecologic Cancer Awareness Month special episode of Axiom Catalyst, Carlie Darefsky, Harish Venkatesan, Flannery Nania, and Luke And...

Over the past few decades, bladder cancer standard of care has not changed, with platinum-based chemotherapy and BCG as the core pillars of care. The last 12 months have seen two new regimens approved for frontline locally advanced / metastatic urothelial and one new treatment approved for BCG-unresponsive CIS NMIBC, significantly improving survival outcomes for patients. Many other clinical progr...

Severe care disparities, barriers to diagnosis, harrowing patient stories, historically low survival… and yet… enduring hope for women worldwide. While significant progress has been made to address needs of women with gynecologic cancers, and the last 12 month have seen huge strides in advancing standards of care, key challenges remain including the inclusivity of clinical studies, asymmetric enga...

Dr. Han Phan is a member of the Pediatric Advisory Board at the FDA, and the Director of Rare Disease Research center. She joins the Axiom Table with Akash Bhattacharjee. This discussion goes though her experience with diagnosing and treating Duchenne patients, challenges faced by manufacturers in this space, and one of the most eagerly anticipated news of the year in Pharma. 

May is ALS Awareness Month and this year Axiom is marking it with a dedicated podcast to help raise awareness about amyotrophic lateral sclerosis (ALS) also known as motor neuron disease. ALS is fatal with the average life expectancy after diagnosis being two to five years, although some patients may live for years or decades. There is still no known cure for ALS and current treatment options prim...

There are~ 30 million people in Europe alone living with a rare condition, of which 75% have neurological symptoms. While significant progress has been made to address needs of these patients, key challenges remain including the scarcity of the expertise and fragmentation of research efforts that translate into delayed diagnosis, few disease modifying therapies, and difficulty in accessing adequat...

While significant therapeutic advances are underway for inherited blood disorders such as sickle cell disease, hemophilia and β-thalassemia, key challenges remain for the commercialization of these therapies, as well as disparities in access to these treatments and level of care received by patients. In this episode of Axiom Catalyst, we invited John James, CEO of Sickle Cell Society to discuss th...

Join Nicole, Kiana, and Madelyn's discussion on updates seen at ASCO GU 2023. We analyze some of the most anticipated read outs in RCC, bladder, and prostate cancers and consider what this data means for physicians and patients.

Join Justin, Rodrigo and Eriko’s discussion on bispecific antibody and CAR-T therapies. These innovative options are increasingly becoming available in late-line treatments for heme cancers. In this episode, we cover the advantages and disadvantages of bispecific and CAR-T treatments, emerging CRS considerations, as well as future directions for both modalities in how they pertain to myeloma and l...

Join Mahim, Samy, & Aman on exciting updates following the ASCO Gastrointestinal Cancers Symposium data readouts as we start 2023 with some exciting updates. In this episode, we share the latest news following recent approvals, 3-year data readouts, and developments in Gastrointestinal, Pancreatic, Colorectal, Hepatocellular Carcinoma, and Biliary Tract Cancer.